Advanced Micro Devices

OliX Pharmaceuticals Announces Results from Preclinical Study of NASH Therapeutic Candidate

Wednesday, August 4, 2021 - 2:00pm

SUWON, Republic of Korea, Aug. 04, 2021 (GLOBE NEWSWIRE) -- OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today presented preclinical data on OLX702A, an investigational therapeutic for the treatment of nonalcoholic steatohepatitis (NASH), at the 48th Korean Academy of Science and Technology (KAST) International Symposium. In the study, OLX702A reversed tissue damage in the liver in a mouse model of NASH.

Key Points: 
  • In the study, OLX702A reversed tissue damage in the liver in a mouse model of NASH.
  • OLX702A is a GalNAc-conjugated asymmetric siRNA (asiRNA) that targets a novel gene which is validated as a NASH-related target based on a genome-wide association study (GWAS).
  • We look forward to progressing development of OLX702A based on these encouraging preclinical data, said Dong Ki Lee, Ph.D., founder and chief executive officer of OliX Pharmaceuticals.
  • OliX has also developed another therapeutic RNAi platform, GalNAc-asiRNA, to target a variety of liver diseases.

EyePoint Pharmaceuticals Reports Second Quarter 2021 Financial Results and Highlights Recent Corporate Developments

Wednesday, August 4, 2021 - 12:00pm

WATERTOWN, Mass., Aug. 04, 2021 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders, today announced financial results for the second quarter ended June 30, 2021 and highlighted recent corporate developments.

Key Points: 
  • We remain on track and look forward to providing top line six-month interim safety and efficacy data in the fourth quarter of this year, said Nancy Lurker, Chief Executive Officer of EyePoint Pharmaceuticals.
  • In July 2021, the Company reported positive 30-day safety results for all cohorts from the DAVIO trial of EYP-1901 for wet-AMD.
  • In June 2021, the Company was added to the small-cap Russell 2000 Index and the broad-market Russell 3000 Index.
  • EyePoint will host a conference call today, at8:30 AM ETto discuss the results for the second quarter ended June 30, 2021 and recent operational developments.

Kala Pharmaceuticals to Present at Upcoming Investor Conferences in August

Wednesday, August 4, 2021 - 1:00pm

WATERTOWN, Mass., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that management will participate in the following virtual healthcare investor conferences in August.

Key Points: 
  • WATERTOWN, Mass., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that management will participate in the following virtual healthcare investor conferences in August.
  • A pre-recorded presentation will be made available beginning Tuesday, August 17, 2021 at 7:00 a.m.
  • To access a webcast and subsequent archived recording of the H.C. Wainwright podium presentation, please visit Events in the Investors section of the Kala website at http://kalarx.com .
  • Kala is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for diseases of the eye.

Eyevensys Raises $12M in a Series B Plus Funding Round

Wednesday, August 4, 2021 - 4:44pm

Eyevensys, a privately held, clinical-stage biotechnology company developing non-viral gene therapies for ophthalmic diseases, today announces it has raised $12M in a Series B Plus funding round.

Key Points: 
  • Eyevensys, a privately held, clinical-stage biotechnology company developing non-viral gene therapies for ophthalmic diseases, today announces it has raised $12M in a Series B Plus funding round.
  • Korea Investment Partners is leading the Series B Plus financing and existing investors will also join the round.
  • We're thrilled to announce this funding round, which will help us move forward in our mission to develop life-changing solutions for patients with debilitating eye diseases, said Dr. Patricia Zilliox, CEO of Eyevensys.
  • Wedbush PacGrow acted as the exclusive placement agent for the Series B Plus financing.

KingHash Creates a "Convenient Mining" Turnkey Intelligent Mining Platform

Wednesday, August 4, 2021 - 10:07am

With hundreds of turnkey mining platforms in the market, platform selection has become a significant problem for investors.

Key Points: 
  • With hundreds of turnkey mining platforms in the market, platform selection has become a significant problem for investors.
  • In view of this demand of investors, KingHash has created a "convenient mining" turnkey mining platform from many factors, such as the quality of the mining pool, the safety degree of the mining process, the technical specialization of the platform, and the post-service situation, so as to help investors realize the complex links of professional miners' selection, deployment, maintenance, and technical service.
  • KingHash is a mining pool established according to the needs of platform users.
  • Industry-leading mining experience, mining machine+cloud computing power is the most representative characteristic technology of KingHash.

Thinking about trading options or stock in Activision Blizzard, BioNTech, Caesars Entertainment, Pfizer, or Advanced Micro Devices?

Wednesday, August 4, 2021 - 2:31pm

NEW YORK, Aug. 4, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ATVI, BNTX, CZR, PFE, and AMD.

Key Points: 
  • NEW YORK, Aug. 4, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ATVI, BNTX, CZR, PFE, and AMD.
  • Click a link below then choose between in-depth options trade idea report or a stock score report.
  • Options Report Ideal trade ideas on up to seven different options trading strategies.
  • The report shows all vital aspects of each option trade idea for each stock.

Primo Water Corporation Announces Appointment of Archana Singh to Board of Directors

Wednesday, August 4, 2021 - 11:45am

TAMPA, Fla., Aug. 4, 2021 /PRNewswire/ - Primo Water Corporation (NYSE: PRMW) (TSX: PRMW) (the "Company" or "Primo"), a leading provider of sustainable drinking water solutions direct to consumers in North America and Europe, today announced the appointment of Archana Singh to the Primo Water Corporation Board of Directors.

Key Points: 
  • TAMPA, Fla., Aug. 4, 2021 /PRNewswire/ - Primo Water Corporation (NYSE: PRMW) (TSX: PRMW) (the "Company" or "Primo"), a leading provider of sustainable drinking water solutions direct to consumers in North America and Europe, today announced the appointment of Archana Singh to the Primo Water Corporation Board of Directors.
  • "Archana brings a wealth of proven executive leadership and is an excellent complement to our existing Board skill set," continued Mr. Fowden.
  • She also held executive-level HR positions at Computer Science Corporation, AMD Corporation, Unisys Corporation, Sun Microsystems and Credit Suisse First Boston.
  • Primo Water Corporation is a leading pure-play water solutions provider in North America, Europe and Israel and generates approximately $2.0 billion in annual revenue.

New AMD Radeon PRO W6000X Series GPUs Bring Groundbreaking High-Performance AMD RDNA 2 Architecture to Mac Pro

Tuesday, August 3, 2021 - 3:37pm

SANTA CLARA, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) -- AMD (NASDAQ: AMD) today announced availability of the new AMD Radeon™ PRO W6000X series GPUs for Mac Pro. The new GPU product line delivers exceptional performance and incredible visual fidelity to power a wide variety of demanding professional applications and workloads, including 3D rendering, 8K video compositing, color correction and more.

Key Points: 
  • New AMD GPUs harness the high-performance, energy efficient AMD RDNA 2 architecture, AMD Infinity Cache and other advanced technologies to power demanding professional design and content creation workloads
    SANTA CLARA, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) -- AMD (NASDAQ: AMD) today announced availability of the new AMD Radeon PRO W6000X series GPUs for Mac Pro.
  • Built on groundbreaking AMD RDNA 2 architecture, AMD Infinity Cache and other advanced technologies, the new workstation graphics line-up includes the AMD Radeon PRO W6900X and AMD Radeon PRO W6800X GPUs.
  • Mac Pro users also have the option of choosing the AMD Radeon PRO W6800X Duo graphics card, a dual-GPU configuration that leverages high-speed AMD Infinity Fabric interconnect technology to deliver outstanding levels of compute performance.
  • Key capabilities and features of AMD Radeon PRO W6000X series GPUs include:
    Award-Winning AMD RDNA 2 Architecture Built on the 7nm manufacturing process, AMD RDNA 2 architecture offers an array of advanced features elevating professional graphics to new levels of performance and efficiency.

Scott+Scott Attorneys at Law LLP Announces Investigation into ATI Physical Therapy Inc. (ATIP)

Monday, August 2, 2021 - 9:47pm

NEW YORK, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (Scott+Scott), an international shareholder and consumer rights litigation firm, is investigating whether ATI Physical Therapy Inc. (ATI or the Company) (NYSE: ATIP), or certain of its officers and directors, violated federal securities laws.

Key Points: 
  • NEW YORK, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (Scott+Scott), an international shareholder and consumer rights litigation firm, is investigating whether ATI Physical Therapy Inc. (ATI or the Company) (NYSE: ATIP), or certain of its officers and directors, violated federal securities laws.
  • ATI and its senior management have touted the Companys growth opportunities through new clinic openings and accelerated hiring.
  • On July 26, 2021, before the market opened, ATI reported its financial results for the second fiscal quarter of 2021.
  • On July 27, 2021, news outlets including the Los Angeles Times reported on a report issued by Barrington Research about ATI.

Winners of COMPUTEX TAIPEI 2021 Best Choice Award Announced Showcasing a New Generation of Digital Transformation Solutions

Monday, August 2, 2021 - 1:30pm

TAIPEI, Aug. 2, 2021 /PRNewswire/ -- Taipei Computer Association (TCA), co-organizer of COMPUTEX TAIPEI, states that COMPUTEX official Best Choice Award (BC Award) is entering its 19th edition.

Key Points: 
  • TAIPEI, Aug. 2, 2021 /PRNewswire/ -- Taipei Computer Association (TCA), co-organizer of COMPUTEX TAIPEI, states that COMPUTEX official Best Choice Award (BC Award) is entering its 19th edition.
  • On July 30, the list of winners is announced through an online premiere with products that cover the latest digital transformation solutions.
  • The winner of the Best Choice of the Year of 2021 is MSI's MEG Aegis Ti5.
  • Best Choice Award is the official award of COMPUTEX TAIPEI.